| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Sign In to gain access to subscriptions and/or personal tools.
|
|
|
|||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Laboratory for Soft Tissue Research, Sports Medicine & Shoulder Service, Hospital for Special Surgery, affiliated with New York Hospital, Cornell University Medical Center, New York, New York
Presented at the 24th annual meeting of the AOSSM, Vancouver, British Columbia, Canada, July 1998.
Address correspondence and reprint requests to Riley J. Williams III, MD, 535 E. 70th Street New York, NY 10021
The pathologic mechanisms underlying fluoroquinolone-induced tendinopathy are poorly understood. The observed incidence of tendinitis and tendon rupture in patients treated with ciprofloxacin hydrochloride suggests that the fluoroquinolone antibiotics alter tendon fibroblast metabolism. The purpose of this study was to examine the effect of ciprofloxacin on fibroblast metabolism in vitro. Canine Achilles tendon, paratenon, and shoulder capsule specimens were maintained in culture with ciprofloxacin (5, 10, or 50 µg/ml). Fibroblast proliferation, collagen synthesis, proteoglycan synthesis, and matrix-degrading activity were analyzed. Incubation of Achilles tendon, Achilles paratenon, and shoulder capsule fibroblasts with ciprofloxacin resulted in a statistically significant 66% to 68% decrease in cell proliferation compared with control cells at day 3 in culture. Ciprofloxacin caused a statistically significant 36% to 48% decrease in collagen synthesis compared with controls in all fibroblast cultures. Ciprofloxacin caused a statistically significant 14% to 60% decrease in proteoglycan synthesis in all fibroblast cell lines. Compared with unstimulated control fibroblasts, culture media from Achilles tendon, paratenon, and shoulder capsule cells that were exposed to ciprofloxacin demonstrated statistically significant increases in matrix-degrading proteolytic activity after 72 hours in culture. This study demonstrates that ciprofloxacin stimulates matrix-degrading protease activity from fibroblasts and that it exerts an inhibitory effect on fibroblast metabolism. The increase in protease activity and the inhibition of both cell proliferation and the synthesis of matrix ground substance may contribute to the clinically described tendinopathies associated with ciprofloxacin therapy.
This article has been cited by other articles:
|
|
 |
|
  A. N. Corps, R. L. Harrall, V. A. Curry, B. L. Hazleman, and G. P. Riley Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells Rheumatology, December 1, 2005; 44(12): 1514 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sharma and N. Maffulli Tendon Injury and Tendinopathy: Healing and Repair J. Bone Joint Surg. Am., January 1, 2005; 87(1): 187 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. KJAeR Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading Physiol Rev, April 1, 2004; 84(2): 649 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Riley The pathogenesis of tendinopathy. A molecular perspective Rheumatology, February 1, 2004; 43(2): 131 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pouzaud, K. Bernard-Beaubois, M. Thevenin, J.-M. Warnet, G. Hayem, and P. Rat In Vitro Discrimination of Fluoroquinolones Toxicity on Tendon Cells: Involvement of Oxidative Stress J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 394 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Corps, V. A. Curry, R. L. Harrall, D. Dutt, B. L. Hazleman, and G. P. Riley Ciprofloxacin reduces the stimulation of prostaglandin E2 output by interleukin-1{beta} in human tendon-derived cells Rheumatology, November 1, 2003; 42(11): 1306 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gold and H. Igra Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature J Am Board Fam Med, September 1, 2003; 16(5): 458 - 460. [Full Text]
|
|
|
|
 |
|
 L. Sarda, A.-C. Cremieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Genin, N. Delahaye, D. Huten, and D. Le Guludec Inability of 99mTc-Ciprofloxacin Scintigraphy to Discriminate Between Septic and Sterile Osteoarticular Diseases J. Nucl. Med., June 1, 2003; 44(6): 920 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Gurbay, C Garrel, M Osman, M-J Richard, A Favier, and F Hincal Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E Human and Experimental Toxicology, December 1, 2002; 21(12): 635 - 641. [Abstract] [PDF]
|
|
|
|
|
|
L. Sarda, A. Saleh-Mghir, C. Peker, A. Meulemans, A.-C. Cremieux, and D. Le Guludec Evaluation of 99mTc-Ciprofloxacin Scintigraphy in a Rabbit Model of Staphylococcus aureus Prosthetic Joint Infection J. Nucl. Med., February 1, 2002; 43(2): 239 - 245. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
